Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
Biologics : Targets & Therapy|October 24, 2009
A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfaseRegina P El Dib, Gregory M PastoresThe Cochrane Database of Systematic Reviews|May 14, 2010
Enzyme replacement therapy for Anderson-Fabry diseaseRegina P El Dib, Gregory M PastoresThe Cochrane Database of Systematic Reviews|March 2, 2013
Enzyme replacement therapy for Anderson-Fabry diseaseRegina P El Dib, Paulo Nascimento, Gregory M PastoresThe Cochrane Database of Systematic Reviews|October 13, 2009
Interventions to promote the wearing of hearing protectionRegina P El Dib, Joseph L MathewBiologics : Targets & Therapy|August 27, 2009
Agalsidase alfa (Replagal) in the treatment of Anderson-Fabry diseaseGregory M PastoresExpert Opinion on Biological Therapy|June 14, 2008
Laronidase (Aldurazyme): enzyme replacement therapy for mucopolysaccharidosis type IGregory M PastoresRecent Patents on CNS Drug Discovery|January 29, 2008
Miglustat: substrate reduction therapy for lysosomal storage disorders associated with primary central nervous system involvementGregory M PastoresHandbook of Clinical Neurology|August 24, 2023
Lysosomal storage disorders: Clinical and therapeutic aspectsGregory M PastoresBest Practice & Research. Clinical Rheumatology|November 26, 2008
Musculoskeletal complications encountered in the lysosomal storage disordersGregory M PastoresContinuum (Minneapolis, Minn.)|July 20, 2012
Leukoencephalopathies and leukodystrophiesGregory M PastoresPageof 11